Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

Not Applicable

Completed

• Conditions: Febrile Morbidity; Pain
• Interventions: Drug: saline; Drug: ketorolac

• Registration Number: NCT00845754
• Lead Sponsor: Ascher-Walsh, Charles, M.D.

Brief Summary

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Detailed Description

Not available

Study Timeline

• Study Start: 1999-09
• Primary Completion: 2001-08
• Study Completion: 2001-08
• Status Verified: 2009-02
• Study First Submitted: 2009-02-14
• Study First Submitted QC: 2009-02-17
• Last Update Submitted: 2009-02-17
• Study First Posted: 2009-02-18
• Last Update Posted: 2009-02-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 112

Inclusion Criteria

• Ant patient undregoing abdominal myomectomy

Exclusion Criteria

• Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	saline	Placebo
2	ketorolac	Ketorolac

Primary Outcome Measures

Name	Time	Method
Post-operative febrile morbidity	Inital 24hrs post-operative

Secondary Outcome Measures

Name	Time	Method
Post-operative pain management	Initial 24hrs post-operative

Trial Locations

Locations (1)

Columbia University Medical Center; 🇺🇸 New York, New York, United States